CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +172,500 | 172,500 | ||
| 2019-02-28 | Saks Samuel R Chief Development Officer | Grant or award | +2,500 | 2,500 | ||
| 2019-02-28 | Saks Samuel R Chief Development Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-02-28 | Shames Richard S. Chief Medical Officer | Grant or award | +8,500 | 32,678 | ||
| 2019-02-28 | Shames Richard S. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +51,000 | 51,000 | ||
| 2019-02-28 | Gupta Suneel EVP Clinical Operations | Grant or award | +7,500 | 17,500 | ||
| 2019-02-28 | Gupta Suneel EVP Clinical Operations | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2019-02-06 | PATEL DINESH V PH D President and CEO | Sale | −777 | $8.10 | $6K | 367,396 |
| 2019-02-06 | PATEL DINESH V PH D President and CEO | Sale | −10,132 | $7.71 | $78K | 357,264 |
| 2019-02-06 | Liu David Y Chief Scientific Officer | Sale | −3,821 | $7.74 | $30K | 37,007 |
| 2019-02-06 | Shames Richard S. Chief Medical Officer | Sale | −198 | $8.15 | $2K | 26,758 |
| 2019-02-06 | Shames Richard S. Chief Medical Officer | Sale | −2,580 | $7.71 | $20K | 24,178 |
| 2019-01-15 | Gupta Suneel EVP Clinical Operations | Option exercise · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2019-01-11 | PATEL DINESH V PH D President and CEO | Option exercise | +22,344 | $1.16 | $26K | 368,173 |
| 2019-01-11 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −22,344 | 22,343 | ||
| 2018-08-15 | O'Neil Thomas P. Chief Financial Officer | Grant or award | +21,100 | 30,560 | ||
| 2018-08-15 | O'Neil Thomas P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +14,050 | 14,050 | ||
| 2018-08-15 | Shames Richard S. Chief Medical Officer | Grant or award | +18,750 | 26,956 | ||
| 2018-08-15 | Shames Richard S. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2018-08-15 | PATEL DINESH V PH D President and CEO | Grant or award | +82,050 | 345,829 |
Page 22 of 29 · 580 trades